Expand AVDL Menu
AVDL MENU

AVDL Stock Summary and Trading Ideas (Avadel Pharmaceuticals PLC - Ordinary Share | NASDAQ:AVDL)

Charts for Today's Stock Price and Implied Volatility in Avadel Pharmaceuticals PLC - Ordinary Share

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for AVDL by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Avadel Pharmaceuticals PLC - Ordinary Share (AVDL) Frequently Asked Questions

What does Avadel Pharmaceuticals PLC - Ordinary Share do?

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.

What symbol and exchange does Avadel Pharmaceuticals PLC - Ordinary Share stock trade?

Avadel Pharmaceuticals PLC - Ordinary Share trades on the NASDAQ stock market under the symbol AVDL.

What is Avadel Pharmaceuticals PLC - Ordinary Share stock price doing today?

As of May 16, 2024, AVDL stock price declined to $15.90 with 10,080 million shares trading.

What is Avadel Pharmaceuticals PLC - Ordinary Share's Beta?

AVDL has a beta of 1.14, meaning it tends to be more sensitive to market movements. AVDL has a correlation of 0.07 to the broad based SPY ETF.

How much is Avadel Pharmaceuticals PLC - Ordinary Share worth?

AVDL has a market cap of $1.53 billion. This is considered a Small Cap stock.

How much money does Avadel Pharmaceuticals PLC - Ordinary Share make?

Last quarter Avadel Pharmaceuticals PLC - Ordinary Share reported $27 million in Revenue and -$.30 earnings per share. This beat revenue expectation by $508,000 and missed earnings estimates by -$.09.

What is the highest and lowest price Avadel Pharmaceuticals PLC - Ordinary Share traded in the last 3 year period?

In the last 3 years, AVDL stock traded as high as $19.09 and as low as $1.05.

What are the top ETFs holding Avadel Pharmaceuticals PLC - Ordinary Share?

The top ETF exchange traded funds that AVDL belongs to (by Net Assets): ONEQ, GWX, AADR, APIE, IBRN.

Is Avadel Pharmaceuticals PLC - Ordinary Share (AVDL) a good investment?

AVDL has underperformed the market in the last year with a price return of +9.6% while the SPY ETF gained +30.0%. However, in the short term, AVDL had mixed performance relative to the market. It has outperformed in the last 3 months, returning +12.0% vs +5.9% return in SPY. But in the last 2 weeks, AVDL shares have been beat by the market, returning -13.2% compared to an SPY return of +5.9%.

What is the support and resistance for Avadel Pharmaceuticals PLC - Ordinary Share (AVDL) stock price?

AVDL support price is $15.44 and resistance is $16.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVDL stock will trade within this expected range on the day.